A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris

Study Identifier
GMA-ACZ-13-001
CT.gov Identifier
NCT02032407
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Dermatology - Acne
    • Study Drug
  • Dapsone Gel
    • Phase
    Phase 4
    Sex
    Female
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosis of acne vulgaris * Medium to dark complexion (Fitzpatrick Skin Type IV, V or VI) * Willing to avoid excessive or prolonged exposure of the face to ultraviolet light (eg, sunlight, tanning beds) throughout the study
    Exclusion Criteria:
    * Received treatment with botulinum toxin of any serotype in the face within 6 months

    Protocol Summary

    This study will evaluate the effect of dapsone gel in female subjects with skin of color (Fitzpatrick Skin Types IV, V, and VI) with acne vulgaris.

    Study Locations

    Location
    Status
    Location
    Washington D.C., District of Columbia, United States
    Status
    Not applicable